| abstract |
The present invention relates to oligonucleotides which are analogs of hsa-miR-503-3p, hsa-miR-328-3p or hsa-miR-6514-5p. The oligonucleotide provided by the present invention can be stably introduced into the human body and effectively inhibit the growth of cancer cells to prevent and/or treat cancer, and in addition to it has wound healing or wound healing promoting activity, and moisturizing the skin when administered to the skin , skin whitening, skin elasticity improvement, skin regeneration, wrinkle improvement, and anti-aging skin improvement effects are excellent, and there is no irritation or side effects on the skin and is safe. |